SOCIETY FOR INHERITED METABOLIC DISORDERS

2004 ANNUAL MEETING

The Peabody Orlando
Orlando, Florida

March 7-10, 2004

PROGRAM:

DAY 1: SUNDAY, MARCH 7
10am – 6:30pm REGISTRATION, Peabody Hotel (by West Entrance)
12:30pm Buses will transport registrants from the Peabody to the Gaylord Palms Resort for Joint Symposium with the American College of Medical Genetics
1:30 – 4:30PM ACMG-SIMD JOINT SYMPOSIUM, Gaylord Palms Resort
Moderators:  Barbara K. Burton, MD and Elaine Spector, PhD
1:30 – 2:00 Enzyme Replacement Therapy for Lysosomal Storage Disorders
Joseph Muenzer, MD, PhD, University of North Carolina at Chapel Hill
2:00 – 2:30 Human GeneTherapy - Risks and Benefits
Christof v. Kalle, MD, Cincinnati Children’s Hospital Research Foundation
2:30 – 3:00 BH4 Therapy for Phenylketonuria
Nenad Blau, PhD, University Children’s Hospital, Zurich, Switzerland
3:00 – 3:30 Break
3:30 – 4:00 Acylcarnitine Analysis in Clinical Practice
Dietrich Matern, MD, Mayo Clinic and Foundation
4:00 – 4:30 New Neurometabolic Disorders including Creatine Disorders
Johan van Hove, MD, University of Colorado Health Science Center
4:45  Buses to transport registrants back to Peabody Hotel (meet outside Convention Center)
7 - 10 PM OPENING   RECEPTION, Peabody Hotel
Sponsored by Ucyclyd Pharma
DAY 2: MONDAY, MARCH 8
7:00 - 8:00 BREAKFAST  Peabody Hotel   (Included in registration)
8:00 - 12:15 NEUROGENETICS
Joel Charrow, MD  Children’s Memorial Hospital, Chicago
8:00 - 8:45 Neuronal Ceroid Lipofuscinosis
Krystyna Wisniewski, MD, PhD, NY State Institute for Research for Developmental Disabilities
8:45 - 9:30 Alexander Disease
Albee Messing, VMD, PhD, University of Wisconsin at Madison
9:30 - 10:15 Dopa-Responsive Dystonia
Yoshiaki Furukawa, MD, Centre for Addiction and Mental Health, Toronto
10:15 - 10:45 Break
10:45 - 11:30 Pelizaeus-Merzbacher and other PLP-Related Disorders
James Garbern, MD, PhD, Wayne State University, Detroit
11:30 - 12:15 Gaucher Disease
Ellen Sidransky, MD, National Institute of Mental Health and Medical Genetics Branch, NHGRI
12:15 - 1:30 LUNCH    (Offered as an option for purchase to meeting registrants)
1:30 - 2:00 SPECIAL GUEST SPEAKER
Marlene E. Haffner, MD, MPh, Director, Office of Orphan Products Development Food and Drug Administration.  “Developing Treatments for Inborn Errors: Incentives Available to the Clinician”
2:00 - 5:30 CONTRIBUTED PAPER SESSION
Stephen I. Goodman, MD, University of Colorado Health Science Center
Topics and presenters will be dependent on the abstracts submitted. A total of 12 papers will be presented.
Presentations will be 10 minutes with 5 minutes for questions and discussion. There will be a 30 minute break during the session.
6:30 DINNER   (Offered as an option for purchase to meeting registrants)
7:30 Board of Directors Meeting
DAY 3: TUESDAY, MARCH 9
7:00 - 8:15 BREAKFAST, Peabody Hotel  (Included in registration)
8:15 - 12:00 NEWBORN SCREENING / TANDEM MASS SPECTROSCOPY
Piero Rinaldo, MD, Moderator, Mayo Clinic and Foundation
8:15 - 8:50 Short Chain Acyl CoA Dehydrogenase Deficiency: What is It? How Should We Diagnose and Treat It?
Dietrich Matern, MD, Mayo Clinic and Foundation
8:50 - 9:25 Glutaric Acidemia type I: Treatment and Outcome
Kevin Strauss, MD, Clinic for Special Children, Strasburg, PA
9:25 - 10:00 Diagnosis and Management of New Inborn Errors of Metabolism Identified through Tandem Mass Spectroscopy
Dwight Koeberl, MD, Duke University Medical Medical Center
10:00 - 10:30 Break
10:30 - 11:05 Spectrum of Fatty Acid Oxidation Disorders Post Newborn  Screening
Arnold Strauss, MD, Vanderbilt University Medical Center
11:05 - 11:40 Error Prevention in the Prenatal Diagnosis of Disorders of Organic Acid and Fatty Acid Metabolism
Piero Rinaldo, MD, PhD, Mayo Clinic and Foundation
11:40 - 12:00 Open Discussion of Issues Related to Newborn Screening
Afternoon Free to Enjoy Activities in the Orlando Area
7:00 - 8:30 DONOUGH O’BRIEN PRESIDENTIAL ADDRESS & Business Meeting of the SIMD
Mendel Tuchman MD, President SIMD
Children’s National Medical Center and The George Washington University
8:30 - 10:00 POSTER SESSION (with refreshments)
DAY 4: WEDNESDAY, MARCH 10
7:00 - 8:00 BREAKFAST, Peabody Hotel (included in registration)
8:00 - 9:30 NEW INSIGHTS ON FAMILIAR DISORDERS
Greta Seashore, MD, Moderator, Yale University School of Medicine
8:00 - 8:45 PKU is a Problem in Biology
Charles Scriver, MD, McGill University, Montreal
8:45 - 9:30 The Relationship between Metabolic Muscle Disorders and Cholesterol- Lowering Drugs
Georgirene Vladutiu, PhD, Women’s and Children’s Hospital of Buffalo
9:30 - 10:00 Break
10:00 - 12:00 NUTRITIONAL ISSUES RELATED TO INBORN ERRORS OF METABOLISM
Rani H. Singh, PhD, RD, Moderator
10:00-10:30 Methods of Evaluating Protein Status in Patients with Inborn Errors of Metabolism
Phyllis Acosta, PhD, RD, Ross Products Division, Abbott Laboratories
10:30-11:00 MCAD Deficiency: Diagnosis and Management. The North Carolina Experience.
Diane Frazier, PhD, MPH, RD, University of North Carolina at Chapel Hill
11:00-11:30 D/G Galactosemia: To Treat or Nor to Treat?
Rani H. Singh, PhD, RD, Emory University School of Medicine
11:30-12:00 Models of Transitions from Pediatric to Adult Care
Christine Trahms, MS, RD, University of Washington
12:00 Meeting Adjourned